SARS News and Research

RSS

How COVID-19 protection conferred by infection is modified by vaccination

The authors of a recent study investigated how vaccination, administered before or after the first COVID-19 infection, modifies the protective effect of the previous infection against reinfection.

29 Nov 2021

COVID-19 surges in the USA, Mexico, and Canada

The authors analyzed the waxing and waning patterns of reported SARS-CoV-2 cases in all states and provinces in the USA, Mexico, and Canada, and across all counties in the USA.

29 Nov 2021

Immunity found 6 months after SARS-CoV-2 infection in children

A new study suggests that infection-induced antibodies persist, providing protection for at least six months.

29 Nov 2021

Do we need COVID-19 vaccine boosters?

An article published recently in the Journal of Virology explored the science behind COVID-19 vaccine boosters.

29 Nov 2021

Immunogenicity of modified microparticle-adjuvanted SARS-CoV-2 vaccine

Researchers investigated the immunogenicity of a novel adjuvant comprised of a modified porous silicon microparticle for the SARS-CoV-2 S protein RBD subunit vaccine.

29 Nov 2021

Severe COVID-19 may result in premature aging in recovered patients

As COVID-19 has been found to cause frontal cortex impairment similar to aging, the scientists in a recent study attempted to investigate if severe COVID-19 resulted in aging-related molecular signatures in the brain. The findings from this study are published as a preprint on the medRxiv* server.

28 Nov 2021

Study suggests making COVID vaccines based on Mu variant

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Mu variant (B.1.621, B.1.621.1) has been tagged as a Variant Being Monitored (VBM), and as of August 30, 2021, it had been detected in 39 countries.

28 Nov 2021

COVID vaccines effectively reduce outbreaks of SARS-CoV-2 alpha and delta viruses in households

A team of UK-based scientists has recently evaluated the effectiveness of coronavirus disease 2019 (COVID-19) vaccines in preventing household transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in England.

28 Nov 2021

Identifying the spread of novel B.1.1.523 SARS-CoV-2

In their recent study, researchers from Lithuania have reported the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant lineage B.1.1.523 containing a set of mutations associated with immune escape, including deletion 156_158del, substitution E484K and S494P in Spike (S) protein.

28 Nov 2021

Study shows plasmacytoid dendritic cells may be a viable target for protection against SARS-CoV-2

A recent research paper by scientists from Denmark reveals that circulating plasmacytoid dendritic cells may be a potential therapeutic target to maintain desired levels of an antiviral compound known as interferon, allowing for the mitigation of coronavirus disease (COVID-19) severity. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.

28 Nov 2021

An analysis of SARS-CoV-2 breakthrough infections by variant and vaccine

Researchers compared the distribution of SARS-CoV-2 genotypes to the prevalence of SARS-CoV-2 variants.

28 Nov 2021

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients

Researchers conducted a Phase II randomized placebo-controlled, double-blinded trial between July 8, 2020, and March 23. 2021.

28 Nov 2021

Low neutralizing antibody titers against SARS-CoV-2 Mu in BNT162b2 vaccinated

Researchers assess the neutralizing antibody titers in BNT162b2-vaccinated people against SARS-CoV-2 isolates from the Mu, Gamma, and B.1.111 lineages.

28 Nov 2021

Using dried blood spots to monitor SARS-CoV-2 antibodies at home

The Roche Elecsys® anti-SARS-CoV-2 S immunoassay was used to demonstrate its ability to measure SARS-CoV-2 antibodies from DBS samples.

28 Nov 2021

How often does SARS-CoV-2 infect alongside another viruses?

Researchers have been exploring data from COVID-19 patients tested at hospitals or clinics that also look for evidence of other diseases.

28 Nov 2021

The introduction and rapid spread of SARS-CoV-2 Gamma in Venezuela

Researchers from the Instituto Venezolano de Investigaciones Científica investigate the introduction of one of the VOCs into Venezuela.

28 Nov 2021

Vaccination provides full protection against severe outcomes of COVID-19 among U.S. Coast Guard

Researchers performed a time-series analysis to evaluate the effectiveness of COVID-19 vaccination in the U.S. CG against SARS-CoV-2 infection.

28 Nov 2021

Seroprevalence study reveals high exposure to SARS-CoV-2 in Bangui population

Researchers performed a cross-sectional study in the city of Bangui, the capital of the Central African Republic from July 12, 2021, to August 20, 2021.

28 Nov 2021

SARS-CoV-2 Omicron variant: What we know so far

On November 24, 2021, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant was first reported to the World Health Organization (WHO) from South Africa.

28 Nov 2021

Complex RNA structures could have untapped therapeutic potential in the fight against COVID-19

To the untrained eye, the loops, kinks and folds in the single strand of RNA that makes up the coronavirus genome look like a jumble of spaghetti or tangled yarn. But to researchers like Amanda Hargrove, a chemistry professor at Duke University, the complex shapes that RNA takes on as it folds upon itself could have untapped therapeutic potential in the fight against COVID-19.

26 Nov 2021

SARS News and Research

How COVID-19 protection conferred by infection is modified by vaccination

COVID-19 surges in the USA, Mexico, and Canada

Immunity found 6 months after SARS-CoV-2 infection in children

Do we need COVID-19 vaccine boosters?

Immunogenicity of modified microparticle-adjuvanted SARS-CoV-2 vaccine

Severe COVID-19 may result in premature aging in recovered patients

Study suggests making COVID vaccines based on Mu variant

COVID vaccines effectively reduce outbreaks of SARS-CoV-2 alpha and delta viruses in households

Identifying the spread of novel B.1.1.523 SARS-CoV-2

Study shows plasmacytoid dendritic cells may be a viable target for protection against SARS-CoV-2

An analysis of SARS-CoV-2 breakthrough infections by variant and vaccine

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients

Low neutralizing antibody titers against SARS-CoV-2 Mu in BNT162b2 vaccinated

Using dried blood spots to monitor SARS-CoV-2 antibodies at home

How often does SARS-CoV-2 infect alongside another viruses?

The introduction and rapid spread of SARS-CoV-2 Gamma in Venezuela

Vaccination provides full protection against severe outcomes of COVID-19 among U.S. Coast Guard

Seroprevalence study reveals high exposure to SARS-CoV-2 in Bangui population

SARS-CoV-2 Omicron variant: What we know so far

Complex RNA structures could have untapped therapeutic potential in the fight against COVID-19

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News